BAKER BROS. ADVISORS LP
Q3 2020 13F-HR Holdings
Net value change ($000)
+2,354,937
(10.4%)
New positions
13
Sold out positions
8
Turnover %
71.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Seagen Inc. | 9,250,154 | NEW |
| ONC | 1,591,269 | 71.7% |
| PRLD | 304,875 | NEW |
| Invitae Corp | 154,773 | 43.1% |
| KOD | 104,958 | 16.8% |
| MyoKardia, Inc. | 104,536 | 34.2% |
| Mirati Therapeutics, Inc. | 73,140 | 45.4% |
| KYMR | 63,302 | NEW |
| NRIX | 62,451 | NEW |
| Global Blood Therapeutics, Inc. | 47,782 | 1610.4% |
Top Reduces (Value $000, Stocks/ETFs)
| Seagen Inc. | -8,032,021 | -100.0% |
| INCY | -455,318 | -13.7% |
| BMRN | -358,671 | -38.3% |
| ACAD | -302,551 | -14.9% |
| AMARIN CORP PLC | -103,918 | -43.5% |
| Principia Biopharma Inc. | -94,520 | -100.0% |
| NBIX | -45,554 | -41.2% |
| DBVT | -38,874 | -60.6% |
| KNSA | -28,443 | -39.9% |
| Atreca, Inc. | -25,824 | -34.4% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|